Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Note: BSYJF = Bushen Yijing Fang.Baseline characteristics of the participants.VariableBSYJF (n = 70)Placebo (n = 70) Demographics Mean age (SD), y63.91 (2.86)63.90 (2.81)Mean height (SD), cm1.56 (0.05)1.55 (0.05)Mean weight (SD), kg52.19 (4.41)52.84 (3.92)Mean BMI (SD), kg/m221.56 (1.51)21.96 (1.46)Mean years since menopause (SD), y14.91 (2.41)14.81 (2.47)Fallers (%), n2 (3%)3 (4%) Disease conditions Mean 25-OH-vitamin D (SD), ng/mL17.84 (4.19)17.87 (4.63)Mean femoral neck BMD (SD), g/cm20.663 (0.029)0.671 (0.018)Median T-score of femoral neck (IQR)−2.20 (0.20)−2.20 (0.20)Mean lean mass of left leg (SD), kg5.47 (0.55)5.50 (0.44)Mean TUG test (SD), s7.60 (0.48)7.66 (0.48)Mean deoxypyridinoline (SD), nmol/mmol7.61 (1.21)7.68 (1.12)Mean osteocalcin (SD), μg/L11.89 (2.33)11.68 (2.16)Mean estradiol (SD), pmol/L36.36 (5.14)35.09 (4.58)Mean endometrial thickness (SD), mm1.87 (0.31)1.79 (0.28)Note: BMI = body mass index; BMD = bone mineral density; TUG = Timed Up and Go, higher scores indicate more severe disease status; BSYJF = Bushen Yijing Fang.
Source: Baseline characteristics. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Double-blind reported · Human research reported
Reported blinded roles: participants, investigators.
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Bushen Yijing Fang Reduces Fall Risk in Late Postmenopausal Women with Osteopenia: A Randomized Double-blind and Placebo-controlled Trial
Source: Article title.
All the participants were recruited via advertisement and provided written informed consent.
Source: Methods.
All the participants, investigators and coordinators were blinded to the treatment assignment.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Bushen Yijing Fang Reduces Fall Risk in Late Postmenopausal Women with Osteopenia: A Randomized Double-blind and Placebo-controlled Trial
Study design awaiting verification · Scientific Reports · 2019
Original publication title
Bushen Yijing Fang Reduces Fall Risk in Late Postmenopausal Women with Osteopenia: A Randomized Double-blind and Placebo-controlled Trial
© The Author(s) 2019
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Falls in late postmenopausal women with osteopenia usually cause fractures with severe consequences. This 36-month randomized, double-blind and placebo-controlled trial with a 10-year observational follow-up study aimed to investigate the long-term effect of herbal formula Bushen Yijing Fang (BSYJF) on fall risk in the late postmenopausal women with osteopenia. 140 late postmenopausal women (Femoral neck T-score, −2.5~−2 SD) were recruited and randomized to orally receive calcium carbonate 300 mg daily with either BSYJF or placebo for 36 months. The effect was further investigated for another 10-year follow-up.
During the 36-month administration, there were 12 falls in BSYJF group and 28 falls in placebo group, respectively, indicating 64% lower risk of falls (RR 0.36 [95% CI, 0.18 to 0.71]; P = 0.004) in BSYJF group. During the 10-year follow-up, 36% lower fall risk (RR 0.64 [95% CI, 0.46 to 0.89]; P = 0.009) was observed in BSYJF group. No significant difference was found in safety profile between two groups. Thirty-six-month administration of BSYJF reduced fall risk with an increase in bone mass, and its latent effect on fall risk was continually observed in the 10-year follow-up in late postmenopausal women with osteopenia.
This clinical trial was registered at Chinese clinical trial registry (ChiCTR-IOR-16008942).
Authors’ abstract
Falls in late postmenopausal women with osteopenia usually cause fractures with severe consequences. This 36-month randomized, double-blind and placebo-controlled trial with a 10-year observational follow-up study aimed to investigate the long-term effect of herbal formula Bushen Yijing Fang (BSYJF) on fall risk in the late postmenopausal women with osteopenia. 140 late postmenopausal women (Femoral neck T-score, −2.5~−2 SD) were recruited and randomized to orally receive calcium carbonate 300 mg daily with either BSYJF or placebo for 36 months. The effect was further investigated for another 10-year follow-up.
During the 36-month administration, there were 12 falls in BSYJF group and 28 falls in placebo group, respectively, indicating 64% lower risk of falls (RR 0.36 [95% CI, 0.18 to 0.71]; P = 0.004) in BSYJF group. During the 10-year follow-up, 36% lower fall risk (RR 0.64 [95% CI, 0.46 to 0.89]; P = 0.009) was observed in BSYJF group. No significant difference was found in safety profile between two groups. Thirty-six-month administration of BSYJF reduced fall risk with an increase in bone mass, and its latent effect on fall risk was continually observed in the 10-year follow-up in late postmenopausal women with osteopenia.
This clinical trial was registered at Chinese clinical trial registry (ChiCTR-IOR-16008942).
Publication and source details
Original title: Bushen Yijing Fang Reduces Fall Risk in Late Postmenopausal Women with Osteopenia: A Randomized Double-blind and Placebo-controlled Trial
Yuxin Zheng; Xuezong Wang; Zong-Kang Zhang; Baosheng Guo; Lei Dang; Bing He; Chi Zhang; Jiwei Zhou; Wanzhong Shi; Yongfang Zhao; Hongsheng Zhan; Yu Xu; Chao Liang; Jin Liu; Daogang Guan; Luyao Wang; Xiaohao Wu; Jie Li; Zhenjian Zhuo; Zhixiu Lin; Hong Qiu; Lidan Zhong; Zhaoxiang Bian; Yinyu Shi; Bao-Ting Zhang; Ge Zhang; Aiping Lu
Scientific Reports · 2019
© The Author(s) 2019https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.https://doi.org/10.13039/501100002920Research Grants Council, University Grants Committee (RGC, UGC)HKBU_47831214112915HKBU_261113Lu AipingRepository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T20:23:24.991686+00:00
DOI: 10.1038/s41598-018-38335-3 · PMC6375933